ANVS

Annovis Bio Inc

May 20 • 04:00PM ET

2.04

+0.10 5.15 %

Healthcare • Biotechnology • USA • Micro • NYSE

Peers: BIVI INMB ALZN NERV TNXP

| Held by: VTI VXF DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.72	Insider Own	8.06%	Shs Outstand	34.65M	Perf Week	-8.11%
Market Cap	70.67M	Forward P/E	-	EPS next Y	-1.31	Insider Trans	41.42%	Shs Float	31.85M	Perf Month	9.68%
Enterprise Value	56.45M	PEG	-	EPS next Q	-0.32	Inst Own	16.52%	Short Float	15.12%	Perf Quarter	-15.35%
Income	-40.92M	P/S	-	EPS this Y	9.64%	Inst Trans	11.34%	Short Ratio	5.60	Perf Half Y	-32.67%
Sales	0.00M	P/B	18.62	EPS next Y	-3.56%	ROA	-190.43%	Short Interest	4.82M	Perf YTD	-41.04%
Book/sh	0.11	P/C	4.97	EPS next 5Y	-8.94%	ROE	-301.13%	52W High	5.50 -62.91%	Perf Year	-4.67%
Cash/sh	0.41	P/FCF	-	EPS past 3/5Y	23.23% -10.15%	ROIC	-1309.11%	52W Low	1.54 32.41%	Perf 3Y	-84.87%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.14% 7.90%	Perf 5Y	-92.27%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	20.55%	Oper. Margin	-	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.27	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.26	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.27	EPS Q/Q	-99.06%	SMA20	-2.16%	Beta	1.30	Target Price	12.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-4.63%	Rel Volume	4.58	Prev Close	1.94
Employees	8	LT Debt/Eq	0.00	Earnings	May 15 BMO	SMA200	-22.51%	Avg Volume	860.80K	Price	2.04
IPO	Jan 29, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-59.49% -	Trades		Volume	3,939,178	Change	5.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)